WCO-IOF-ESCEO 2027 – World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Vienna

Key facts

  • Edition: 27th congress
  • Venue: VIECON Congress Center, Messeplatz 1, Vienna
  • Organisers: Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) and the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
  • Audience: experts in musculoskeletal health and disease
  • CME: European, American and Belgian accreditation in process
  • Recordings: on-demand videos on the congress platform for three months after the event

WCO-IOF-ESCEO 2027 is the 27th World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases. The organizers describe it as the world's leading clinical congress on bone, joint and muscle health. The scientific programme covers research, clinical insights and therapeutic advances, with a focus on bone metabolism, musculoskeletal pathologies and new approaches to prevention, diagnosis and treatment.

On the first day, the WHO-ESCEO Bone and Joint Innovative Session takes place just before the Opening Ceremony. It looks at innovation in both osteoporosis and osteoarthritis, and three awards are presented there. The programme also includes non-sponsored symposia and award applications, and abstract submission is open on the congress website.

Certificates appear on the eCongress platform a few days after the meeting. The CME certificate requires the online evaluation form, and for online attendees CME points depend on how long they watched the sessions.

Recent editions show the reach of the meeting: the 2026 congress received a record 1,819 abstract submissions, and the 2025 congress in Rome had 8,667 registrants, 3,998 on site and 4,669 online. That edition was accredited with 23.5 European CME credits. The congress is managed by Sinklar Conference Management, and the venue is reached by metro line U2 at Messe-Prater station.

For related clinical guidance, see the medpresso overview of European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

*Please note that medpresso.org is an independent entity and is not associated with the official organization of this event. Please refer to the official website through the provided link for additional information.